List of products by brand Sandoz

Sandoz, a Novartis division, is a pioneer and a global leader in biosimilars. We invest in research and development to improve the lives of patients and liberate healthcare resources through increased access to high-quality, affordable biologics.

Sandoz, a Novartis division, is a pioneer and a global leader in biosimilars. We invest in research and development to improve the lives of patients and liberate healthcare resources through increased access to high-quality, affordable biologics.

With eight marketed biosimilars across immunology, oncology and endocrinology, we also have a leading biosimilars pipeline with more than 15 molecules in various stages of development.

After initiating the world’s first biosimilar development program 25 years ago, we went on to receive the world’s first approval of a biosimilar in Europe in 2006. Then, in 2009, we received the first marketing authorization of biosimilars in Japan and Canada^, and opened the US market with the first biosimilars approval in 2015.

Our biosimilars have been used in clinical practice for over 15 years, are available in approx. 100 countries with over 970 million patient-days of experience.